Abstract:For this theme issue, we have called upon experts in the field of study of brain changes in high-risk patients with prodromal symptoms or with a first episode of schizophrenia, whether it takes place in childhood, adolescence, or adulthood. The evidence—or lack thereof—that currently exists for progressive brain changes is discussed in this theme issue by some of the leading groups in the field. The set of reviews starts with an elegant historical background on the cyclical issue of progressive brain changes in schizophrenia. The longitudinal magnetic resonance imaging studies from Edinburgh and Melbourne in prodromal subjects and subjects at increased genetic risk are then reviewed by their investigators. And finally, bringing us full circle, progressive changes after a first schizophrenia episode and in children and adolescents with early-onset psychosis are the last 2 reviews of this theme issue. Overall, the different lines of evidence suggest that some structures appear abnormal before the first sign of any symptom and therefore during a first episode, while some of these same structures and others show a higher than expected volume loss over time and thus appear different at follow-up when compared with healthy controls. These progressive changes seem to be present during the initial years after the first episode and continue even in the more chronic phase of the illness. Theresultsofthedifferentstudiesreviewedherecould be explained by separate disease processes taking place at different times in the lives of patients with schizophrenia or a single ongoing process beginning during brain development and accelerating after maximum cranial volume is reached. 1,2 Brain insults early in development, either in utero or ex utero, may affect maturational processes. In turn, earlyand latematurational processes, eg, regressive or pruning processes, result in dynamic changes in the structure of the brain well into the second and third decade of life and even later. 3 These normal processes of brain maturation, leading to decreased cortical volume, could be exaggerated in patients with schizophrenia and lead to greater than expected decreases in cortical volume and increases in sulcal cerebrospinal fluid, in the absence of neurodegeneration. Excessivebrainvolumelossoccurringmayalsobeaconsequence rather than a cause of illness, with variables such as psychosis, stress, and drug treatment playing a role in brain volume loss. 4–6 Therefore, if we attempt to integrate the findings from the studies reviewed in this issue, we would suggest that early and late neurodevelopmental abnormalities may be present in varying degrees in patients with schizophrenia. Some of these may be under genetic control, other may be the result of environmental effects. Finally, progressive changes need to be addressed, not only from the aspect of volumetric brain changes but also at the molecular, cellular, and neurochemical level, and the findings will need to be related to the influence of genetic and environmental

Brain Volume Changes in First-Episode Schizophrenia

Brain Volume Changes in First-Episode Schizophrenia

Changes in First-Episode Schizophrenia A 1-Year Follow-up Study

Volume Changes in Gray Matter in Patients with Schizophrenia.

Progressive Brain Volume Loss in Schizophrenia over the Course of the Illness: Evidence of Maturational Abnormalities in Early Adulthood

Brain Volume Changes in the First Year of Illness and 5-Year Outcome of Schizophrenia

Decrease in Temporal Gyrus Gray Matter Volume in First-Episode, Early Onset Schizophrenia: an MRI Study.

Excessive Brain Volume Loss Over Time In Cannabis-Using First-Episode Schizophrenia Patients

Brain Volumes in Schizophrenia: a Meta-Analysis in over 18 000 Subjects.

Progressive Brain Changes in Schizophrenia

Focal Gray Matter Changes in Schizophrenia across the Course of the Illness: A 5-Year Follow-Up Study

Brain Morphology in Antipsychotic-Naïve Schizophrenia: a Study of Multiple Brain Structures.

Gray Matter Volume Changes Following Antipsychotic Therapy in First-Episode Schizophrenia Patients: A Longitudinal Voxel-Based Morphometric Study.

The Course of Brain Abnormalities in Schizophrenia: Can We Slow the Progression?

Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia

Brain Volume Changes after Withdrawal of Atypical Antipsychotics in Patients with First-Episode Schizophrenia

Psychosis and brain volume changes during the first five years of schizophrenia.

Brain Volumes As Predictor of Outcome in Recent-Onset Schizophrenia: A Multi-Center Mri Study

Abnormal grey matter changes in first-episode antipsychotic-na?ve patients with adolescent-onset schizophrenia

Progressive Brain Structural Changes after the First Year of Treatment in First-Episode Treatment-Naive Patients with Deficit or Nondeficit Schizophrenia

Brain Volume Reductions in Medication-Naive Patients with Schizophrenia in Relation to Intelligence Quotient